09/09/2026
argenx prioritizes patients and is committed to providing them with solutions. Learn more about argenx's enrolling clinical trials, including the Phase 3 emvigorate and emnergize trials in adults with CIDP.
https://na2.hubs.ly/H073nnX0
https://na2.hubs.ly/H073xdQ0
https://na2.hubs.ly/H073xSc0
CIDP, chronic inflammatory demyelinating polyradiculoneuropathy.
Disclaimer: This is a paid sponsored post. The views and content presented are those of the sponsor and do not constitute an endorsement by AANEM.